Press Releases

 
Press Releases
  Date Title and Summary View
Jul 15, 2011
Biocept, Inc. announced today that it has appointed William G. Kachioff as Senior Vice President, Finance and Chief Financial Officer. As CFO, Mr. Kachioff will be responsible for management of the company’s accounting, finance, treasury, investor relations, risk management and information systems functions. Kachioff has more than 20 years...
Jun 2, 2011
Biocept, Inc. today reported that its scientists and academic collaborators will present a poster at the 2011 Annual Meeting of the American Society of Clinical Oncology (ASCO) taking place in Chicago, Illinois June 3?7. The poster presentation is based on studies performed utilizing Biocept’s proprietary OncoCEE™ (Oncology Cell Enri...
May 10, 2011
San Diego, California: ? Biocept, Inc., a privately?held laboratory testing company focused on the detection, enumeration and analysis of circulating tumor cells (CTCs) in cancer patients, today announced the publication of a paper describing the identification of different CTC phenotypes using its proprietary Cell Enrichment and Extraction (CEE...
Apr 22, 2011
SAN DIEGO / — Biocept, Inc. announced today that Lyle Arnold, PhD and Michael Dunn, MBA have joined Biocept’s Management Team. Dr. Arnold will serve as Senior Vice President and Chief Scientific Officer (CSO) and Mr. Dunn will act as the Senior Vice President, Corporate Development. “I am very excited about the addition...
Apr 11, 2011
The Board of Biocept, Inc. announced today that David F. Hale has joined the Board as Executive Chairman and Ivor Royston, M.D. as a Director. Mr. Hale and Dr. Royston first worked together at Hybritech, San Diego’s first biotech company, of which Dr. Royston was a co?founder and director, and Mr. Hale served as President and COO and as CE...
Sep 28, 2010
Biocept, Inc. (“Biocept”), an emerging leader in biotechnology, announced today the appointment of Bruce E. Gerhardt as Director. “We are pleased to welcome Bruce to our Board. His experience will be invaluable to us as we move into our next stage of development,” said Stephen M. Coutts, President and CEO. ...
Aug 30, 2010
In the midst of a $5 million financing round, microfluidics company Biocept is looking to launch its first diagnostic test, as it embarks on “redefining what a circulating tumor cell is.” Thirteen years after its founding, and following changes in its technology focus and other adaptations, the company plans to soon launch it...
Aug 20, 2010
We noted earlier this week that San Diego?based Biocept, which is developing advanced cancer diagnostics technology, had recently raised $2.3 million from its investors. That news reminded me of a fascinating meeting I had in June with Biocept CEO Stephen Coutts, a 30?year veteran of San Diego’s biotech community. In one of ...
Jul 1, 2009
Biocept, Inc. (“Biocept”), an emerging leader in biotechnology, announced today the appointment of Daniel H. Petree and M. Faye Wilson as Directors. “We are pleased to welcome Dan and Faye to our Board. Their experience will be invaluable to us as we move into our next stage of development,” said Stephen M. Coutts...
Dec 3, 2008
Biocept, Inc. (“Biocept”), an emerging leader in biotechnology, announced today their CLIA laboratory has been awarded accreditation by the Commission on Laboratory Accreditation of the College of American Pathologists (CAP), based on the results of a recent on?site inspection. Biocept, Inc. (“Biocept”), an emergi...
Page: FirstPrevious ...
18
= add release to Briefcase